Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gritstone Oncology
Biotech
Gritstone ground down by phase 2 cancer vaccine fail
The cancer vaccine failed to trigger hoped-for changes in circulating tumor DNA, causing the phase 2 clinical trial to miss its primary endpoint.
Nick Paul Taylor
Apr 2, 2024 5:09am
Gritstone lays off 40% of team after delaying COVID vax trial
Feb 29, 2024 4:05pm
Gritstone gets $433M in BARDA funds to trial mRNA COVID-19 shot
Sep 28, 2023 5:54am
Gritstone taps Genevant to power up infectious disease vaccines
Aug 15, 2023 10:00am
2 more biotechs report pipeline, partnership changes
May 12, 2023 11:15am
Next-gen COVID shots need differentiation, pan-variant potential
Jan 24, 2022 10:53am